Early Detection of Parkinson's Disease

2019 ◽  
pp. 61-95
Author(s):  
Debashree Devi ◽  
Saroj K. Biswas ◽  
Biswajit Purkayastha
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Early Detection ◽  
Neurodegenerative Disorder ◽  
Diagnostic System ◽  
Diagnostic Model ◽  
Neural Signals ◽  
Learning Machine ◽  
Preprocessing Technique ◽  
Thalamic Region

Parkinson's disease (PD) is a neurodegenerative disorder that occurs due to corrosion of the substantia nigra, located in the thalamic region of the human brain, and is responsible for transmission of neural signals throughout the human body by means of a brain chemical, termed as “dopamine.” Diagnosis of PD is difficult, as it is often affected by the characteristics of the medical data of the patients, which include presence of various indicators, imbalance cases of patients' data records, similar cases of healthy/affected persons, etc. Through this chapter, an intelligent diagnostic system is proposed by integrating one-class SVM, extreme learning machine, and data preprocessing technique. The proposed diagnostic model is validated with six existing techniques and four learning models. The experimental results prove the combination of proposed method with ELM learning model to be highly effective in case of early detection of Parkinson's disease, even in presence of underlying data issues.

Early Detection of Parkinson's Disease

2021 ◽  
pp. 295-328
Author(s):  
Debashree Devi ◽  
Saroj K. Biswas ◽  
Biswajit Purkayastha
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Early Detection ◽  
Neurodegenerative Disorder ◽  
Diagnostic System ◽  
Diagnostic Model ◽  
Neural Signals ◽  
Learning Machine ◽  
Preprocessing Technique ◽  
Thalamic Region

Parkinson's disease (PD) is a neurodegenerative disorder that occurs due to corrosion of the substantia nigra, located in the thalamic region of the human brain, and is responsible for transmission of neural signals throughout the human body by means of a brain chemical, termed as “dopamine.” Diagnosis of PD is difficult, as it is often affected by the characteristics of the medical data of the patients, which include presence of various indicators, imbalance cases of patients' data records, similar cases of healthy/affected persons, etc. Through this chapter, an intelligent diagnostic system is proposed by integrating one-class SVM, extreme learning machine, and data preprocessing technique. The proposed diagnostic model is validated with six existing techniques and four learning models. The experimental results prove the combination of proposed method with ELM learning model to be highly effective in case of early detection of Parkinson's disease, even in presence of underlying data issues.

scholarly journals An optimized RNN-LSTM approach for parkinson’s disease early detection using speech features

2021 ◽  
Vol 10 (5) ◽  
pp. 2503-2512
Author(s):  
Hadeel Ahmed Abd El Aal ◽  
Shereen A. Taie ◽  
Nashwa El-Bendary
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Early Detection ◽  
Short Term Memory ◽  
Neurodegenerative Disorder ◽  
Classification Performance ◽  
The Body ◽  
Testing Dataset ◽  
Benchmark Datasets ◽  
Speech Features

Parkinson's disease (PD) is the second most common neurodegenerative disorder disease right after Alzheimer's and the most common movement disorder for elderly people. It is characterized as a progressive loss of muscle control, which leads to trembling characterized by uncontrollable shaking, or (tremors) in different parts of the body. In recent years, deep learning (DL) models achieved significant progress in automatic speech recognition, however, limited studies addressed the problem of distinguishing people with PD for further clinical diagnosis. In this paper, an approach for the early detection of patients with PD using speech features was proposed, a recurrent neural network (RNN) with long short-term memory (LSTM) is applied with the batch normalization layer and adaptive moment estimation (ADAM) optimization algorithm used after the network hidden layers to improve the classification performance. The proposed approach is applied with 2 benchmark datasets of speech features for patients with PD and healthy control subjects. The proposed approach achieved an accuracy of 95.8% and MCC=92.04% for the testing dataset. In future work, we aim to increase the voice features that will be worked on and consider using handwriting kinematic features.

scholarly journals An Optimized Brain-Based Algorithm for Classifying Parkinson’s Disease

2020 ◽  
Vol 10 (5) ◽  
pp. 1827 ◽  
Author(s):  
Rodrigo Olivares ◽  
Roberto Munoz ◽  
Ricardo Soto ◽  
Broderick Crawford ◽  
Diego Cárdenas ◽  
...  
Keyword(s):  
Machine Learning ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Extreme Learning Machine ◽  
Neurodegenerative Disorder ◽  
Fine Tuning ◽  
Machine Learning Techniques ◽  
Learning Approaches ◽  
Classification Problems ◽  
Learning Machine

During the last years, highly-recognized computational intelligence techniques have been proposed to treat classification problems. These automatic learning approaches lead to the most recent researches because they exhibit outstanding results. Nevertheless, to achieve this performance, artificial learning methods firstly require fine tuning of their parameters and then they need to work with the best-generated model. This process usually needs an expert user for supervising the algorithm’s performance. In this paper, we propose an optimized Extreme Learning Machine by using the Bat Algorithm, which boosts the training phase of the machine learning method to increase the accuracy, and decreasing or keeping the loss in the learning phase. To evaluate our proposal, we use the Parkinson’s Disease audio dataset taken from UCI Machine Learning Repository. Parkinson’s disease is a neurodegenerative disorder that affects over 10 million people. Although its diagnosis is through motor symptoms, it is possible to evidence the disorder through variations in the speech using machine learning techniques. Results suggest that using the bio-inspired optimization algorithm for adjusting the parameters of the Extreme Learning Machine is a real alternative for improving its performance. During the validation phase, the classification process for Parkinson’s Disease achieves a maximum accuracy of 96.74% and a minimum loss of 3.27%.

scholarly journals Different Classification Approaches for Early Detection of Parkinson’s Disease

2021 ◽  
Author(s):  
Nikita Aggarwal ◽  
Jasleen Saini ◽  
B.S. Saini ◽  
Savita Gupta
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Early Detection ◽  
Continuous Monitoring ◽  
Neurodegenerative Disorder ◽  
Diagnostic Process ◽  
Research Directions ◽  
Non Motor Symptoms ◽  
Aided Diagnosis

Parkinson’s disease is perhaps the most well-known neurodegenerative disorder that mainly occurs due to the loss of dopamine-producing neurons and consists of motor/non-motor symptoms. The progression of the symptoms is often varying from one person to another to the diversity of the disease. The condition causes a huge burden both on those affected, as well as their families. Accurate diagnosis is critical and challenging but still, no specific diagnostic process is available. The computer-aided diagnosis techniques of signalling and imaging processing are very helpful in the prediction and classification of PD. This review gives a brief description of different methods of classification for early detection and also highlights the most profitable research directions by focusing on continuous monitoring patterns of daily activities, interactions, and routine that may provide the data on status changes, clinical management, and controlling self-correction

scholarly journals A Sensor-Based Perspective in Early-Stage Parkinson’s Disease: Current State and the Need for Machine Learning Processes

Sensors ◽  
2022 ◽  
Vol 22 (2) ◽  
pp. 409
Author(s):  
Marios G. Krokidis ◽  
Georgios N. Dimitrakopoulos ◽  
Aristidis G. Vrahatis ◽  
Christos Tzouvelekis ◽  
Dimitrios Drakoulis ◽  
...  
Keyword(s):  
Machine Learning ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Neurodegenerative Disorder ◽  
Early Stage ◽  
Diagnostic System ◽  
Medical Systems ◽  
Body Protein ◽  
Ensemble Techniques ◽  
Current State

Parkinson’s disease (PD) is a progressive neurodegenerative disorder associated with dysfunction of dopaminergic neurons in the brain, lack of dopamine and the formation of abnormal Lewy body protein particles. PD is an idiopathic disease of the nervous system, characterized by motor and nonmotor manifestations without a discrete onset of symptoms until a substantial loss of neurons has already occurred, enabling early diagnosis very challenging. Sensor-based platforms have gained much attention in clinical practice screening various biological signals simultaneously and allowing researchers to quickly receive a huge number of biomarkers for diagnostic and prognostic purposes. The integration of machine learning into medical systems provides the potential for optimization of data collection, disease prediction through classification of symptoms and can strongly support data-driven clinical decisions. This work attempts to examine some of the facts and current situation of sensor-based approaches in PD diagnosis and discusses ensemble techniques using sensor-based data for developing machine learning models for personalized risk prediction. Additionally, a biosensing platform combined with clinical data processing and appropriate software is proposed in order to implement a complete diagnostic system for PD monitoring.

Rapid Diagnosis of Parkinson’s Disease from Sebum using Paper Spray Ionisation Ion Mobility Mass Spectrometry

2020 ◽  
Author(s):  
Depanjan Sarkar ◽  
Drupad Trivedi ◽  
Eleanor Sinclair ◽  
Sze Hway Lim ◽  
Caitlin Walton-Doyle ◽  
...  
Keyword(s):  
Mass Spectrometry ◽  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Ion Mobility ◽  
Neurodegenerative Disorder ◽  
Treatment Options ◽  
Ion Mobility Mass Spectrometry ◽  
Paper Spray ◽  
Molecular Features ◽  
Validation Set

Parkinson’s disease (PD) is the second most common neurodegenerative disorder for which identification of robust biomarkers to complement clinical PD diagnosis would accelerate treatment options and help to stratify disease progression. Here we demonstrate the use of paper spray ionisation coupled with ion mobility mass spectrometry (PSI IM-MS) to determine diagnostic molecular features of PD in sebum. PSI IM-MS was performed directly from skin swabs, collected from 34 people with PD and 30 matched control subjects as a training set and a further 91 samples from 5 different collection sites as a validation set. PSI IM-MS elucidates ~ 4200 features from each individual and we report two classes of lipids (namely phosphatidylcholine and cardiolipin) that differ significantly in the sebum of people with PD. Putative metabolite annotations are obtained using tandem mass spectrometry experiments combined with accurate mass measurements. Sample preparation and PSI IM-MS analysis and diagnosis can be performed ~5 minutes per sample offering a new route to for rapid and inexpensive confirmatory diagnosis of this disease.

Visual Effects of Deep Brain Stimulation in a Patient with Parkinson’s Disease

2019 ◽  
pp. 158-173
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Deep Brain Stimulation ◽  
Visual System ◽  
Brain Stimulation ◽  
Neurodegenerative Disorder ◽  
Initial Examination ◽  
Before And After ◽  
Deep Brain ◽  
Cover Test

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder caused by a dopamine deficiency that presents with motor symptoms. Visual disorders can occur concomitantly but are frequently overlooked. Deep brain stimulation (DBS) has been an effective treatment to improve tremors, stiffness and overall mobility, but little is known about its effects on the visual system. Case Report: A 75-year-old Caucasian male with PD presented with longstanding binocular diplopia. On baseline examination, the best-corrected visual acuity was 20/25 in each eye. On observation, he had noticeable tremors with an unsteady gait. Distance alternating cover test showed exophoria with a right hyperphoria. Near alternating cover test revealed a significantly larger exophoria accompanied by a reduced near point of convergence. Additional testing with a 24-2 Humphrey visual field and optical coherence tomography (OCT) of the nerve and macula were unremarkable. The patient underwent DBS implantation five weeks after initial examination, and the device was activated four weeks thereafter. At follow up, the patient still complained of intermittent diplopia. There was no significant change in the manifest refraction or prism correction. On observation, the patient had remarkably improved tremors with a steady gait. All parameters measured were unchanged. The patient was evaluated again seven months after device activation. Although vergence ranges at all distances were improved, the patient was still symptomatic for intermittent diplopia. OCT scans of the optic nerve showed borderline but symmetric thinning in each eye. All other parameters measured were unchanged. Conclusion: The case found no significant changes on ophthalmic examination after DBS implantation and activation in a patient with PD. To the best of the authors’ knowledge, there are no other cases in the literature that investigated the effects of DBS on the visual system pathway in a patient with PD before and after DBS implantation and activation.

Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease

2019 ◽  
Vol 26 (20) ◽  
pp. 3719-3753 ◽  
Author(s):  
Natasa Kustrimovic ◽  
Franca Marino ◽  
Marco Cosentino
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Immune System ◽  
Neurodegenerative Disorder ◽  
Neurodegenerative Process ◽  
Progressive Degeneration ◽  
Cytokine Levels ◽  
Inflammatory Phenotype ◽  
Immune Challenges

:Parkinson’s disease (PD) is the second most common neurodegenerative disorder among elderly population, characterized by the progressive degeneration of dopaminergic neurons in the midbrain. To date, exact cause remains unknown and the mechanism of neurons death uncertain. It is typically considered as a disease of central nervous system (CNS). Nevertheless, numerous evidence has been accumulated in several past years testifying undoubtedly about the principal role of neuroinflammation in progression of PD. Neuroinflammation is mainly associated with presence of activated microglia in brain and elevated levels of cytokine levels in CNS. Nevertheless, active participation of immune system as well has been noted, such as, elevated levels of cytokine levels in blood, the presence of auto antibodies, and the infiltration of T cell in CNS. Moreover, infiltration and reactivation of those T cells could exacerbate neuroinflammation to greater neurotoxic levels. Hence, peripheral inflammation is able to prime microglia into pro-inflammatory phenotype, which can trigger stronger response in CNS further perpetuating the on-going neurodegenerative process.:In the present review, the interplay between neuroinflammation and the peripheral immune response in the pathobiology of PD will be discussed. First of all, an overview of regulation of microglial activation and neuroinflammation is summarized and discussed. Afterwards, we try to collectively analyze changes that occurs in peripheral immune system of PD patients, suggesting that these peripheral immune challenges can exacerbate the process of neuroinflammation and hence the symptoms of the disease. In the end, we summarize some of proposed immunotherapies for treatment of PD.

Current Therapeutic Strategies and Perspectives for Neuroprotection in Parkinson’s Disease

2020 ◽  
Vol 26 (37) ◽  
pp. 4738-4746
Author(s):  
Mohan K. Ghanta ◽  
P. Elango ◽  
Bhaskar L. V. K. S.
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Early Diagnosis ◽  
Neurodegenerative Disorder ◽  
Therapeutic Strategies ◽  
Neuroprotective Agents ◽  
Striatal Neurons ◽  
The Status ◽  
Advanced Stages ◽  
Dopaminergic Pathways

Parkinson’s disease is a progressive neurodegenerative disorder of dopaminergic striatal neurons in basal ganglia. Treatment of Parkinson’s disease (PD) through dopamine replacement strategies may provide improvement in early stages and this treatment response is related to dopaminergic neuronal mass which decreases in advanced stages. This treatment failure was revealed by many studies and levodopa treatment became ineffective or toxic in chronic stages of PD. Early diagnosis and neuroprotective agents may be a suitable approach for the treatment of PD. The essentials required for early diagnosis are biomarkers. Characterising the striatal neurons, understanding the status of dopaminergic pathways in different PD stages may reveal the effects of the drugs used in the treatment. This review updates on characterisation of striatal neurons, electrophysiology of dopaminergic pathways in PD, biomarkers of PD, approaches for success of neuroprotective agents in clinical trials. The literature was collected from the articles in database of PubMed, MedLine and other available literature resources.

Sign in / Sign up

Export Citation Format

Share Document